Next-Generation ALK-Targeted Agents in NSCLC

preview_player
Показать описание
Mark A. Socinski, MD, provides insight on the use of next-generation ALK-targeted agents up front in patients with non–small cell lung cancer.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Next-Generation ALK-Targeted Agents 0:02:50

Next-Generation ALK-Targeted Agents in NSCLC

2023 Best of 0:30:32

2023 Best of Lung: Targeted Therapies in Lung Cancer

Next-Generation Targeted Therapies 0:07:44

Next-Generation Targeted Therapies in Non-Small Cell Lung Cancer

Next-Generation ALK Inhibitors 0:06:41

Next-Generation ALK Inhibitors for NSCLC

First and Second 0:22:10

First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer

Upfront Use of 0:06:54

Upfront Use of Next-Generation ALK Inhibitors in NSCLC

Efficacy of Next-Generation 0:04:23

Efficacy of Next-Generation ALK Inhibitors in NSCLC

ALK and ROS1 0:40:53

ALK and ROS1 in Lung Cancer Next Generation Targeted Therapies

Next-Generation ALK Inhibitors 0:05:53

Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer

Keynote Lecture: Targeted 0:33:52

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

Next Generation ALK 0:08:35

Next Generation ALK Inhibitors for NSCLC

Sequencing Therapy in 0:05:30

Sequencing Therapy in ALK/ROS1-Rearranged NSCLC

Dr. Rotow on 0:01:02

Dr. Rotow on the Implications of Next-Generation ALK Inhibitors in NSCLC

Emerging ALK/ROS1 TKIs 0:04:49

Emerging ALK/ROS1 TKIs for NSCLC

Utilizing Next-Generation ALK 0:05:18

Utilizing Next-Generation ALK Inhibitors in NSCLC

Targeted Therapy Resistance 0:02:48

Targeted Therapy Resistance Mechanisms in ALK+ NSCLC

Segment 2: Molecular 0:26:57

Segment 2: Molecular Targets in NSCLC

ALK Inhibitor Sequencing 0:06:27

ALK Inhibitor Sequencing in NSCLC

Dr. Herbst on 0:01:18

Dr. Herbst on Next-Generation Agents in NSCLC

The Evolution of 0:04:05

The Evolution of ALK/ROS1-Targeted Therapy in NSCLC

ALK-Positive NSCLC: ALEX 0:04:31

ALK-Positive NSCLC: ALEX Trial

Sequencing Strategies for 0:06:36

Sequencing Strategies for ALK-Targeted Therapy

ALK Positive Lung 0:42:31

ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw

Progression in ALK+ 0:06:51

Progression in ALK+ NSCLC After Frontline Therapy